The certification allows the company to commercialize the product in the Switzerland and European Economic Area (EEA).
Apollo is a pulmonary image analysis solution designed to detect, evaluate and treat pulmonary disease including chronic obstructive pulmonary disease (COPD), emphysema, lung cancer and asthma.
Vida Diagnostics said that its analysis methodology has been tested in multiple academic and clinical trials.
